DrugPatentWatch Database Preview
DESVENLAFAXINE Drug Profile
When do Desvenlafaxine patents expire, and when can generic versions of Desvenlafaxine launch?
The generic ingredient in DESVENLAFAXINE is desvenlafaxine succinate. There are sixteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the desvenlafaxine succinate profile page.
Summary for DESVENLAFAXINE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 11 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 72 |
| Clinical Trials: | 61 |
| Patent Applications: | 773 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | DESVENLAFAXINE at DailyMed |
Pharmacology for DESVENLAFAXINE
Medical Subject Heading (MeSH) Categories for DESVENLAFAXINE
Synonyms for DESVENLAFAXINE
| 130198-08-2 |
| 93414-04-1 |
| CHEMBL3039565 |
| Desvenlafaxine fumarate |
| O-Desmethylvenlafaxine fumarate |
| Phenol, 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)-, (2E)-2-butenedioate (1:1) (salt) |
| Phenol, 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)-, (E)-2-butenedioate (1:1) (salt) |
| SCHEMBL3400998 |
| SCHEMBL521350 |
| SQTJDJZCPOSWSC-WLHGVMLRSA-N |
US Patents and Regulatory Information for DESVENLAFAXINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharms Ltd | DESVENLAFAXINE | desvenlafaxine | TABLET, EXTENDED RELEASE;ORAL | 204150-001 | Mar 4, 2013 | BC | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| West-ward Pharms Int | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204082-002 | Aug 28, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Actavis Labs Fl | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204065-001 | Jul 29, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Sun Pharma Global | DESVENLAFAXINE | desvenlafaxine fumarate | TABLET, EXTENDED RELEASE;ORAL | 205583-002 | Jan 28, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
